As part of its lecture series on Infection & Immunity, the Luxembourg Institute of Health (LIH) is organising a lecture on the topic ‘Frontiers in inflammation research: From NLRP3 to metabolic reprogramming’. The lecture takes place on Wednesday, 18 April 2018.
Prof Luke O’Neill is Chair of Biochemistry at Trinity College Dublin where he leads the Inflammation Research Group, Co-founder of 2 Spin-out companies – Opsona Therapeutics and Inflazome, Dublin, Ireland.
The LIH Lecture Series and Workshops on Infection and Immunity, supported through the FNR’s RESCOM: Scientific Events programme, gather internationally recognised speakers to address topics around Infection and Immunity.
Time and location
Lecture: 11:00 – 12:00
Lycée Technique d’Esch/Alzette – Salle de projection audiovisuelle
Meet & Eat: 12:30 – 14:00 (registration required)
House of BioHealth, Room Françoise Barré-Sinoussi